Direct answer:There is no uniform “Chinese drug FDA registration” route for Chinese preparations, herb extracts or Chinese medicines entering the United States. Facilities, labels and declarations shall be determined by determining the route of general foodstuffs, dietary supplements or medicines, respectively, in conjunction with the complete composition, formulation, mode of use, intended use and full declaration.

Classification first, then processing:“Natural” “herbs” or pharmaceutical approvals in China do not directly define United States regulatory categories. Food facility registration numbers, NDCs or a component document are not a substitute for judging the product’s route to the market.

I. Determining the path of herbal products, what facts do we see first?

  • What is it?Complete formulations, botanical names, uses, processing or extraction methods, supplements and quantities per use.
  • How to use:Oral or external use, agent type, frequency of use, target population and mode of sale.
  • Say what?Whether the overall presentation of packaging labels, websites, advertisements, electricity providers and social media is related to the use of disease.
  • Who is responsible for:Manufacturing facilities, brand parties, importers, labelers and existing registered or technical information.

Product classifications should not look only at the Chinese name, nor should they review only the front of the packaging. Different uses and declarations are used for the same herbal feedstocks, which may involve different requirements. The complete facts should be retained before the legal path was assessed, rather than the category of less formality.

ii. What are the checks to be made as a general food or food package?

When used as daily foods, beverages, spices or ingredients of food, the legality of the use, the conditions of use and the adequacy of the safety grounds for the use and the checking of food additives, GRAS or other applicable grounds shall be established. China’s management of medicinal substances or traditional consumption history does not directly presume that all United States food uses and quantities are accepted.

The registration of facilities is only one element. Labelling, food safety, importer responsibility and cargo declaration should be assessed separately; Specific requirements may also exist for special foods or processing methods. The next step to viewU.S. compliance process for food exports、Food label reviewandFood facility registration and renewal。

III. What is the focus on as a dietary supplement?

Dietary supplements are a category of products in the regulatory framework for food subject to their statutory definitions and other requirements; It cannot be judged solely on the appearance of capsules, tablets or powders. Assessments should be made of how components, food patterns, labels and products are presented to consumers.

Composition and NDI:To confirm the identity of the dietary composition, the way it is processed, the historical basis and the applicability of the New Dietary Ingredient (new dietary component) notification. Not all herbal components are subject to NDI notification, and are not automatically exempted from use of natural plants. Where applicable, the relevant safety basis shall be submitted to the FDA at least 75 days before the dietary supplement containing this component enters the interstate commerce; Submission of a notification does not amount to approval of the product.

Labels and claims:Supply Facts, composition, usage and warnings should be consistent with product information. The applicable structure/function claims to be supported, to use a statutory disclaimer and to notify the FDA no later than 30 days after the initial sale of the dietary supplement; Such notification does not make it possible to comply with claims of treatment.

Formulas, plant names, extraction processes, quantities and labels in English may be submitted first.Food and dietary supplemental servicesConfirmation of the scope of the assessment; NDI, security evaluation or special testing should identify the workload and costs separately.

IV. Why assess the path of medicines when it comes to the use of disease?

Grass products intended for diagnosis, treatment, mitigation, cure or prevention of diseases may be pharmaceutical products. It is not presumed that sales can be legally made for that purpose by renaming “health goods”, by completing only the registration of food facilities or by acquiring NDC.

Botanical Drug is an area of development related to plant-sourced medicines and is not a simple register route. The need for development and listing applications such as IND, NDA and quality, safety and effectiveness information should be assessed in conjunction with specific products. China’s approved or traditional use experience is available as information to be assessed and is not a direct substitute for the application of the United States requirements.

OTC also doesn't mean that any herbs can follow a monograph path. The conditions of the active ingredient, concentration, agent type, use and labelling need to be verified item by item; Other pathways should be further assessed if they do not. ViewableOTC Monograph IntroductionandDirection of pharmaceutical formulation services, first communicate the facts of the product and the information gaps.

Are the above-mentioned three categories also applicable to outer-use herb products?

It should not be mechanically applied. External products used to clean, glorify or improve appearances may involve cosmetics; The treatment of the disease or the use that affects the physical structure and functioning of the body may involve medicines, and some products may fall into both categories. The composition, use and overall declaration should be assessed and the requirements of MoCRA and so forth should be re-judged.

All expensive herb products cannot be processed using food or dietary supplemental pathways. FromCosmetics classification and applicability judgementStart checking.

VI. How should enterprises move forward and how should cycles and budgets be estimated?

  1. To organize the product facts:Provide complete formulations, botanical names, processing processes, quantities used, target population, existing labels and full sales declarations.
  2. To form a list of path judgements and questions:Distinguishing identified grounds, information gaps and matters requiring further professional verification.
  3. Split jobs by path:Identification of components safety, labelling, facility matters, import arrangements and, where applicable, NDI or pharmaceutical development.
  4. Confirm commission and ongoing maintenance:Clear delivery of information, liability of parties, cost composition, retention of records and arrangements for subsequent changes.

There is no uniform “registration cycle” and “official registration fee” applicable to all Chinese medicines or herb products. The information and procedures required for the development of general foodstuffs, dietary supplements and medicines vary widely; Initial assessments, testing or security information, application of official procedures and service costs should be estimated separately. NDI’s 75-day requirement is not the same time that all herb products are listed in the market.

VII. FACTUAL ISSUES

Can domestic medicines be sold directly as a dietary supplement to the United States?It cannot be decided by name conversion alone. The conformity of products with the definition of dietary supplementation, the legitimacy of components and the requirements of use and declaration should be assessed first.

Can the word disease be deleted from the package and the food route be changed?It cannot be judged directly. There is also a need to evaluate the formula, actual use and overall presentation of websites, advertisements, etc., and not to change the text to just one text.

After the food registration has been completed, does it indicate that the herb composition has been accepted by the FDA?No. The facility registration does not validate all product components, uses or declarations; The composition and product requirements still need to be checked separately.

Official sources and next entry points

Enterprises with defined product categories, if availableFDA Service OverviewSelect the corresponding direction; When classification is not clear, the product facts are provided, the scope of the assessment is communicated, and it is not appropriate to place a list of registered goods directly for the application of food or medicines.

Submission of information on herbal products, communication of applicable pathways

Official data checks and updates: 2026-11-06. Author: Mr. Otsun; Audit: Mr. Toto. This document is a guide to initial path identification, and the classification and application requirements depend on the complete product facts and the existing rules.

Continue reading and preparation

Further consolidation of project information is availableFDA Product Classification and Compliance Services Overview; The scope, processing cycles and costs are shown on the corresponding service page.